<div class="d-flex flex-column w-100 h-100 px-3 pb-3 bg-reports-background">
    <div class="d-flex py-2 my-1 gap-2 align-items-center text-white">
        <div class="d-flex align-items-center justify-content-center gap-2 cursor-pointer" (click)="handleNavigation()">
            <img class="w-10" src="assets/icons/left-arrow-blue.svg" />
            <div class="fw-400 fs-14 text-home-link">Home</div>
        </div>
        <img class="w-7" src="assets/icons/chevron-right-blue.svg" />
        <div class="fw-400 fs-14">Projects</div>
        <img class="w-7" src="assets/icons/chevron-right-blue.svg" />
        <div class="fw-400 fs-14">DIAGNOSIS AND SURVEILLANCE OF INDETERMINATE PULMONARY NODULES</div>
    </div>
    <div class="d-flex flex-column mx-auto p-4 gap-2 reports-container">
        <h4 style="color: #b2ffb2;">DIAGNOSIS AND SURVEILLANCE OF INDETERMINATE PULMONARY NODULES</h4>
        <div class="fs-14 login-signup-button login-btn" style="width: fit-content;" (click)="requestAccess()">Request
            Access</div>
        <h6 class="text-white mt-3 fs-15">Description</h6>
        <p class="mb-1 me-4 fw-400 fs-14 reports-description">
            The main objective of this trial is to improve the efficiency of the diagnostic evaluation of patients with
            indeterminate pulmonary nodules. The trial will determine the diagnostic accuracy of biomarkers for lung
            cancer measured in minimally-invasive and non-invasive biospecimens, and whether these genomic and proteomic
            biomarkers in the airway and blood can distinguish between high-risk smokers with malignant or benign
            indeterminate, incidentally-detected pulmonary nodules.
        </p>
        <div class="fs-14 login-signup-button" style="width: fit-content;">Learn More</div>
        <h6 class="text-white mt-3 fs-15">Participants</h6>
        <p class="mb-1 me-4 fw-400 fs-14 reports-description">

            Patients enrolled will be 45 years or older, have been diagnosed with indeterminate pulmonary nodules within
            the year prior to enrollment (size at time of consent must be: 0.7 to 3.0 cm), and have a smoking status as
            a current or former smoker with >=220 pa
        </p>
        <h6 class="text-white mt-3 fs-15">Desease Stage</h6>
        <p class="mb-1 me-4 fw-400 fs-14 reports-description">
            Lung
        </p>
        <h6 class="text-white mt-3 fs-15">Response Endpoint</h6>
        <p class="mb-1 me-4 fw-400 fs-14 reports-description">
            Patients enrolled will be 45 years or older, have been diagnosed with indeterminate pulmonary nodules within
            the year prior to enrollment (size at time of consent must be: 0.7 to 3.0 cm), and have a smoking status as
            a current or former smoker with 220 pa
        </p>
        <h6 class="text-white mt-3 fs-15">Modality</h6>
        <p class="mb-1 me-4 fw-400 fs-14 reports-description">
            CT
        </p>
    </div>
</div>